Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Sep;95(1):197–208. doi: 10.1111/j.1476-5381.1988.tb16565.x

Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

S M Gardiner 1, A M Compton 1, T Bennett 1
PMCID: PMC1854148  PMID: 2975521

Abstract

1. The regional haemodynamic effects of i.v. bolus doses of atrial natriuretic peptide (ANP, 1 and 10 nmol), calcitonin gene-related peptide (CGRP, 0.05 and 0.5 nmol) and corticotropin-releasing factor (CRF, 1 and 5 nmol) were assessed in conscious Long Evans and Brattleboro rats chronically instrumented with miniaturized, pulsed Doppler probes. 2. The low dose of ANP was without effect on mean arterial pressure (MAP), but caused tachycardia and hindquarters vasodilatation with vasoconstriction in renal and mesenteric beds in Long Evans rats. With the high doses of ANP these effects were more pronounced and MAP fell. In Brattleboro rats there was a primary renal vasodilatation. 3. The low dose of CGRP caused a slight fall in MAP in Long Evans rats, tachycardia and a renal vasodilatation. The high dose of CGRP caused marked hypotension, tachycardia and renal, mesenteric and hindquarters vasodilatation in both strains of rat. However, only in Long Evans rats were there secondary renal and mesenteric vasoconstrictions. 4. The low dose of CRF caused falls in MAP in both strains of rat, accompanied by renal and, particularly, mesenteric vasodilatation. Administration of the high dose of CRF caused profound, prolonged hypotension, tachycardia and mesenteric vasodilatation. There was also (late onset) hindquarters vasodilatation accompanying renal vasoconstriction that followed the initial vasodilatation in this vascular bed. 5. These results indicate that appropriate doses of particular peptides may be capable of promoting flow through individual peripheral vascular beds.

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burnett J. C., Jr, Granger J. P., Opgenorth T. J. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol. 1984 Nov;247(5 Pt 2):F863–F866. doi: 10.1152/ajprenal.1984.247.5.F863. [DOI] [PubMed] [Google Scholar]
  2. Calcutt C. R., Ganellin C. R., Griffiths R., Leigh B. K., Maguire J. P., Mitchell R. C., Mylek M. E., Parsons M. E., Smith I. R., Young R. C. Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist. Br J Pharmacol. 1988 Jan;93(1):69–78. doi: 10.1111/j.1476-5381.1988.tb11406.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dashwood M. R., Andrews H. E., Wei E. T. Binding of [125I]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium. Eur J Pharmacol. 1987 Mar 3;135(1):111–112. doi: 10.1016/0014-2999(87)90766-7. [DOI] [PubMed] [Google Scholar]
  4. DiFrancesco D., Ferroni A., Mazzanti M., Tromba C. Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node. J Physiol. 1986 Aug;377:61–88. doi: 10.1113/jphysiol.1986.sp016177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gardiner S. M., Bennett T. Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats. Clin Sci (Lond) 1985 Jun;68(6):647–657. doi: 10.1042/cs0680647. [DOI] [PubMed] [Google Scholar]
  6. Gardiner S. M., Bennett T. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol. 1988 Jan;93(1):9–22. doi: 10.1111/j.1476-5381.1988.tb11400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  8. Kinter L. B., Shier D., Flamenbaum W., Beeuwkes R., 3rd The renin angiotensin system in conscious Brattleboro strain rats. Ren Physiol. 1982;5(6):278–285. doi: 10.1159/000172868. [DOI] [PubMed] [Google Scholar]
  9. Lappe R. W., Slivjak M. J., Todt J. A., Wendt R. L. Hemodynamic effects of calcitonin gene-related peptide in conscious rats. Regul Pept. 1987 Dec;19(5-6):307–312. doi: 10.1016/0167-0115(87)90172-8. [DOI] [PubMed] [Google Scholar]
  10. Lappe R. W., Smits J. F., Todt J. A., Debets J. J., Wendt R. L. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ Res. 1985 Apr;56(4):606–612. doi: 10.1161/01.res.56.4.606. [DOI] [PubMed] [Google Scholar]
  11. Lappe R. W., Todt J. A., Wendt R. L. Hemodynamic effects of infusion versus bolus administration of atrial natriuretic factor. Hypertension. 1986 Oct;8(10):866–873. doi: 10.1161/01.hyp.8.10.866. [DOI] [PubMed] [Google Scholar]
  12. Lappe R. W., Todt J. A., Wendt R. L. Mechanism of action of vasoconstrictor responses to atriopeptin II in conscious SHR. Am J Physiol. 1985 Dec;249(6 Pt 2):R781–R786. doi: 10.1152/ajpregu.1985.249.6.R781. [DOI] [PubMed] [Google Scholar]
  13. Lappe R. W., Todt J. A., Wendt R. L. Regional vasodilator actions of calcitonin gene-related peptide in conscious SHR. Peptides. 1987 Jul-Aug;8(4):747–749. doi: 10.1016/0196-9781(87)90052-0. [DOI] [PubMed] [Google Scholar]
  14. MacCannell K. L., Lederis K., Hamilton P. L., Rivier J. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation. Pharmacology. 1982;25(2):116–120. doi: 10.1159/000137732. [DOI] [PubMed] [Google Scholar]
  15. MacLean M. R., Ungar A. Effects of the renin-angiotensin system on the reflex response of the adrenal medulla to hypotension in the dog. J Physiol. 1986 Apr;373:343–352. doi: 10.1113/jphysiol.1986.sp016051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marshall I., Al-Kazwini S. J., Holman J. J., Craig R. K. Human and rat alpha-CGRP but not calcitonin cause mesenteric vasodilatation in rats. Eur J Pharmacol. 1986 Apr 16;123(2):217–222. doi: 10.1016/0014-2999(86)90662-x. [DOI] [PubMed] [Google Scholar]
  17. Marshall I., Al-Kazwini S. J., Roberts P. M., Shepperson N. B., Adams M., Craig R. K. Cardiovascular effects of human and rat CGRP compared in the rat and other species. Eur J Pharmacol. 1986 Apr 16;123(2):207–216. doi: 10.1016/0014-2999(86)90661-8. [DOI] [PubMed] [Google Scholar]
  18. Murad F., Leitman D. C., Bennett B. M., Molina C., Waldman S. A. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation. Am J Med Sci. 1987 Sep;294(3):139–143. doi: 10.1097/00000441-198709000-00003. [DOI] [PubMed] [Google Scholar]
  19. Satoh M., Oku R., Maeda A., Fujii N., Otaka A., Funakoshi S., Yajima H., Takagi H. Possible mechanisms of positive inotropic action of synthetic human calcitonin gene-related peptide in isolated rat atrium. Peptides. 1986 Jul-Aug;7(4):631–635. doi: 10.1016/0196-9781(86)90038-0. [DOI] [PubMed] [Google Scholar]
  20. Scheuer D. A., Thrasher T. N., Quillen E. W., Jr, Metzler C. H., Ramsay D. J. Atrial natriuretic peptide blocks renin response to renal hypotension. Am J Physiol. 1987 Feb;252(2 Pt 2):R423–R427. doi: 10.1152/ajpregu.1987.252.2.R423. [DOI] [PubMed] [Google Scholar]
  21. Sigrist S., Franco-Cereceda A., Muff R., Henke H., Lundberg J. M., Fischer J. A. Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology. 1986 Jul;119(1):381–389. doi: 10.1210/endo-119-1-381. [DOI] [PubMed] [Google Scholar]
  22. Smits J. F., van Essen H., Struyker-Boudier H. A., Lappe R. W. Lack of renal vasodilation during intrarenal infusion of synthetic atriopeptin II in conscious intact SHR. Life Sci. 1986 Jan 6;38(1):81–87. doi: 10.1016/0024-3205(86)90278-x. [DOI] [PubMed] [Google Scholar]
  23. Standaert D. G., Cechetto D. F., Needleman P., Saper C. B. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature. 1987 Sep 10;329(6135):151–153. doi: 10.1038/329151a0. [DOI] [PubMed] [Google Scholar]
  24. Thorén P., Mark A. L., Morgan D. A., O'Neill T. P., Needleman P., Brody M. J. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol. 1986 Dec;251(6 Pt 2):H1252–H1259. doi: 10.1152/ajpheart.1986.251.6.H1252. [DOI] [PubMed] [Google Scholar]
  25. Udelsman R., Gallucci W. T., Bacher J., Loriaux D. L., Chrousos G. P. Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. Peptides. 1986 May-Jun;7(3):465–471. doi: 10.1016/0196-9781(86)90016-1. [DOI] [PubMed] [Google Scholar]
  26. Udelsman R., Harwood J. P., Millan M. A., Chrousos G. P., Goldstein D. S., Zimlichman R., Catt K. J., Aguilera G. Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature. 1986 Jan 9;319(6049):147–150. doi: 10.1038/319147a0. [DOI] [PubMed] [Google Scholar]
  27. Wright C. E., Angus J. A., Korner P. I. Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli. Hypertension. 1987 Feb;9(2):122–131. doi: 10.1161/01.hyp.9.2.122. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES